This article is more than 5 years old. Information may no longer be current.

Stryker, AlloSource announce partnership to distribute biologics for sports medicine procedures

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

At the Arthroscopy Association of North American Annual Meeting, Stryker’s Sport Medicine business and AlloSource announced a collaboration to offer high-quality, innovative biologics for sports medicine procedures.

“We believe biologics will play a critical role in advancing the field of sports medicine, so we are excited about the opportunity to collaborate with AlloSource given their history of quality and innovation,” Matt Moreau, vice president and general manager of Stryker’s Sports Medicine business, said in the release. “The collaboration between Stryker and AlloSource will enable us to combine our unique areas of expertise to develop new ways to improve patient outcomes.”

According to the release, Stryker’s Sports Medicine sales force will distribute AlloSource biologics for various sports medicine procedures.

Reference:

www.sportsmedicine.stryker.com